PEOPLE - Cytogen makes appointment:
This article was originally published in Clinica
Cytogen has appointed one of its directors, Dr John Bagalay Jr, interim chief financial officer. He replaces TJ Madison who left the US company due to "differences over the business strategies of the company".
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.